Maze Therapeutics
We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. (Incorporated in Delaware) We are advancing a pipeline using our Compass platform, which allows us to identify and characterize genetic variants in disease […]
January 8, 2025 Read More